XCR Diagnostics Inc (XCR Diagnostics) is a designer and developer of real-time PCR assays. The company’s products include brucella abortus detection assay, brucella ovis detection assay and custom real time PCR master mix. It offers services such as assay design services, assay design and confirmation services, assay consulting, custom chemical formulation, custom research and development and assay validation, radiance genotyping, and reorder and quality assurance services. XCR Diagnostics also provides sequences of primers, sequences of the fluorescent probes, oligonucleotide sequences, oligonucleotide alignment and amplification protocol. The company serves universities, clinical laboratories, and pharmaceutical companies globally. XCR Diagnostics is headquartered in Salt Lake City, Utah, the US.
This report is a source for data, analysis, and actionable intelligence on the company’s portfolio of pipeline products. The report provides key information about the company, its major products and brands.
The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage.
Note: Some sections may be missing if data is unavailable for the company
This report is a source for data, analysis, and actionable intelligence on the company’s portfolio of pipeline products. The report provides key information about the company, its major products and brands.
The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage.
Scope:
- The report reviews detailed company profile with information on business description, key company facts, major products and services, key competitors, key employees, locations and subsidiaries and recent developments
- The report analyzes all pipeline products in development for the company XCR Diagnostics Inc
- The report provides pipeline analysis on all pipeline products of the company (by equipment type, by indication, by development stage, and by trial status)
- The report covers detailed information on each pipeline product with information on pipeline territory, stage of development, device class, regulatory path, indication(s), application(s) and estimated launch date
- The report provides detailed description of products in development, technical specification and functions
- The report also covers ongoing clinical trials (wherever applicable) with information on trial name, trial objective, sponsor, trial design , trial status and phase, estimated start and end date.
Reasons to Buy:
- Develop business strategies by understanding the trends and developments driving the medical devices pipeline and technology landscape
- Design and develop your product development, marketing and sales strategies by understanding the competitor portfolio
- To formulate effective Research & Development strategies
- Develop market-entry and market expansion strategies
- Exploit in-licensing and out-licensing opportunities by identifying products, most likely to ensure a robust return
- Plan mergers and acquisitions effectively by identifying key players of the most promising pipeline
- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
- Develop competition strategies by identifying the status and likely launch of the competitors’ pipeline products through review of the clinical trials, stage and of development, etc
- Identify, understand and capitalize the next high-value products that your competitor would add in its portfolio
Note: Some sections may be missing if data is unavailable for the company
Table of Contents
- XCR Diagnostics Inc Company Overview
- XCR Diagnostics Inc Company Snapshot
- XCR Diagnostics Inc Pipeline Products and Ongoing Clinical Trials Overview
- XCR Diagnostics Inc - Pipeline Analysis Overview
- XCR Diagnostics Inc - Key Facts
- XCR Diagnostics Inc - Major Products and Services
- XCR Diagnostics Inc Pipeline Products by Development Stage
- XCR Diagnostics Inc Pipeline Products Overview
- COVID-19 Test
- COVID-19 Test Product Overview
- Pyramid Portable Nucleic Acid Testing System
- Pyramid Portable Nucleic Acid Testing System Product Overview
- Pyramid System - BP/BPP Assay
- Pyramid System - BP/BPP Assay Product Overview
- Pyramid System - C. Difficile Assay
- Pyramid System - C. Difficile Assay Product Overview
- Pyramid System - Enterovirus/Paraechovirus Assay
- Pyramid System - Enterovirus/Paraechovirus Assay Product Overview
- Pyramid System - Group A Strep Assay
- Pyramid System - Group A Strep Assay Product Overview
- Pyramid System - Group B Strep Assay
- Pyramid System - Group B Strep Assay Product Overview
- Pyramid System - HSV-1/HSV-2/VZV Assay
- Pyramid System - HSV-1/HSV-2/VZV Assay Product Overview
- Pyramid System - Influenza A/B And RSV Assay
- Pyramid System - Influenza A/B And RSV Assay Product Overview
- Pyramid System - MRSA Assay
- Pyramid System - MRSA Assay Product Overview
- Pyramid System - Norovirus Assay
- Pyramid System - Norovirus Assay Product Overview
- XCR Assay - Group C Streptococcus
- XCR Assay - Group C Streptococcus Product Overview
- XCR Assay - Group G Streptococcus
- XCR Assay - Group G Streptococcus Product Overview
- XCR Diagnostics Inc - Key Competitors
- XCR Diagnostics Inc - Key Employees
- XCR Diagnostics Inc - Locations And Subsidiaries
- Head Office
Recent Developments
Appendix
List of Tables
List of Figures
Companies Mentioned (Partial List)
A selection of companies mentioned in this report includes, but is not limited to:
- Athena Diagnostics Inc
- NanoLogix Inc
- Indigo Biosciences Inc